HighTower Advisors’s Affimed AFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-7
Closed -$7K 3038
2020
Q4
$7K Sell
7
-3,893
-100% -$183K ﹤0.01% 2526
2020
Q3
$40K Buy
3,900
+2,300
+144% +$87.1K ﹤0.01% 2317
2020
Q2
$40K Sell
1,600
-4,700
-75% -$131K ﹤0.01% 2206
2020
Q1
$11K Sell
6,300
-4,500
-42% -$107K ﹤0.01% 2113
2019
Q4
$39K Buy
10,800
+2,800
+35% +$74.9K ﹤0.01% 2137
2019
Q3
$48K Buy
8,000
+1,800
+29% +$53.6K ﹤0.01% 2230
2019
Q2
$47K Sell
6,200
-1,000
-14% -$33.7K ﹤0.01% 2212
2019
Q1
$103K Buy
7,200
+5,700
+380% +$205K ﹤0.01% 2056
2018
Q4
$12K Hold
1,500
﹤0.01% 2116
2018
Q3
$12K Buy
+1,500
New +$42.5K ﹤0.01% 2194

Other funds holding AFMD

HighTower Advisors's AFMD Position: Q1 2024 in Review

HighTower Advisors sold out of Affimed (AFMD) in Q1 2024, closing a stake of 1,100 shares — an estimated $7K sold.

HighTower Advisors first reported a position in AFMD in Q3 2018 and held it in 12 quarters. The position peaked at $138K in Q3 2019. 46 funds tracked by Wall St. Rank hold AFMD as of Q1 2024.

  • HighTower Advisors reported no remaining Affimed position as of Q1 2024 after selling out during the quarter.
  • HighTower Advisors sold 1,100 Affimed shares in Q1 2024, an estimated $7K.
  • HighTower Advisors first reported a position in Affimed in Q3 2018 and held it in 12 quarters.
  • HighTower Advisors's Affimed position peaked at $138K in Q3 2019.
  • 46 funds tracked by Wall St. Rank held Affimed as of Q1 2024.

Based on HighTower Advisors's 13F filing for Q1 2024, filed 6 May 2024.